Intraluminal GI Photobiomodulation With Reflectance Feedback

Instead of delivering light from outside the body through the skin (traditional approach), the patent inverts the delivery approach by placing light sources inside the GI tract. The system uses intraluminal devices that are swallowed or inserted into the GI tract, allowing light to be delivered directly to the target tissue from within the lumen, thereby overcoming the penetration depth limitation without requiring invasive surgical procedures.

The patent introduces an intermediary delivery system - intraluminal devices containing light sources that travel through the GI tract. These devices serve as mediators between the external light source and the internal GI tract tissue, enabling deep tissue penetration while maintaining a non-invasive external interface. The devices can be swallowed capsules or inserted through the mouth, avoiding surgical incisions.

The patent employs disposable intraluminal devices that are swallowed or inserted into the GI tract, perform their therapeutic function, and then naturally pass through the digestive system to be expelled. These single-use devices eliminate the need for expensive, complex, reusable systems with sterilization requirements. The devices are designed to be inexpensive enough to be discarded after one use, significantly reducing patient burden and healthcare costs.

The intraluminal devices are designed to be self-contained and self-operating. They contain integrated light sources, control circuits, and power supplies that automatically deliver the prescribed photobiomodulation therapy without requiring external control or monitoring during operation. The devices navigate the GI tract independently and expel themselves naturally, eliminating the need for complex external manipulation equipment and specialized medical personnel intervention.